Skip to content

Clinical trials

Phase 3 Melanoma trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 3 Country / region: Portugal Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20101
20111
20121
20132
20141
20172
20182
20201
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated6
Active, not recruiting4
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Bristol-Myers Squibb3
Hoffmann-La Roche3
Amgen2
Novartis Pharmaceuticals2
Pfizer2
Memorial Sloan Kettering Cancer Center1
Merck Sharp & Dohme LLC1
Nektar Therapeutics1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma22
Neoplasm Metastasis4
Skin Neoplasms4
Skin Diseases2
Brain Neoplasms1
Fever1
Neoplasms1
Ovarian Neoplasms1
Pyloric Stenosis, Hypertrophic1
Sarcoma1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.